LEDGER verified prices only — no fake movement NexLife tirzepatide $139/mo ✓ 08-20 NexLife semaglutide $119/mo ✓ 08-20 Brand pens list $1,000–1,350 mfr list Zepbound vials direct ~$349–499 verify Mochi Health pending verification Ro pending Hims pending Henry Meds pending LEDGER verified prices only — no fake movement NexLife tirzepatide $139/mo ✓ 08-20 NexLife semaglutide $119/mo ✓ 08-20 Brand pens list $1,000–1,350 mfr list Zepbound vials direct ~$349–499 verify Mochi Health pending verification Ro pending Hims pending Henry Meds pending
Online GLP-1
ProvidersThe GLP-1 price ledger
Every price dated & sourced · conflicts disclosed
Ozempic · Wegovy · Mounjaro · Zepbound · Compounded GLP-1s

Find your cheapest safe GLP-1 —
without the games.

Brand pens list at $1,000+ a month at the pharmacy. The lowest verified price in our ledger for a compounded online program is $139/mo — dated, sourced, all fees counted. We track 11 providers so the fine print gets read before your card does.

The number that matters is the 12-month all-in: for the verified floor, that's $1,668 — in writing.
Brand list price
$1,059+/mo
Verified online floor
$139–$299/mo

Not the same product: brand pens are FDA-approved; online programs are mostly compounded. The difference, plainly — and insurance coverage, where you have it, can beat both.

Check today's ledger
#1 verified NexLife — tirzepatide$139/mo · 12-mo plan
low cash NexLife — semaglutide$119/mo · 12-mo plan
queue Mochi · Ro · Hims · Henry + 6 morepending verification

Verified 2026-08-20 against provider plan pages. All 11 tracked programs, every fee field: see the full ledger →

The table

Verified picks, and the honest queue

Scored on our published rubric only after a dated checkout verification. Ten of eleven rows are still in the queue — we'd rather show you a short honest table than a full invented one.

Get your personalized match →
#ProviderScorePriceTypeInsurance
1
NexLife verified 08-20
Cash-pay buyers who want the maintenance-dose price known on day one — dose-flat, rate-locked, $0 membership/consults
9.1
$139–169
/mo tirzepatide · $119–139 sema
Compounded No Profile →
2
Ro
Insurance-first buyers wanting brand Zepbound/Wegovy with coverage navigation
pending
verification queued Brand Yes Record →
3
Mochi Health
Specialist-led care: obesity-medicine physicians, membership + medication model
pending
verification queued Compounded No Compare →
4
Henry Meds
Flat-subscription positioning; early large compounded brand
pending
verification queuedCompoundedNoRecord →
5
Hims / Hers
Mass-market platforms; semaglutide emphasis plus brand pathways
pending
verification queuedCompoundedVariesRecord →
6
Orderly · Remedy · Shed · Found · Fifty 410
The long tail most roundups skip — same 18-field verification, same queue
pending
verification queuedCompoundedVariesAll →
Score rubric (published, /methodology/): price transparency, true-cost vs advertised, dose-flat behavior, fee load, exit terms, evidence alignment of formats sold. NexLife 9.1 = perfect transparency/fee/exit marks, docked for low-evidence ODT line and pharmacy-partner fields still unpublished. Pending rows are unscored — a score without a dated verification would be fiction. Disclosure: our operator has a material relationship with NexLife — details.
NexLife9.1/10

Lowest verified true cost in the ledger; price = maintenance price, locked. Docked for ODT evidence gap.

$139/mo · tirzepatide, 12-mo
Read the profile →
Mochi Healthpending

The specialist-led counterargument to flat pricing: obesity-medicine physicians, flexible prescribing.

TBD · membership + medication
See the head-to-head →
Insurance routecheck first

Covered brand Zepbound/Wegovy plus savings card can beat every cash price on this page. Always check before buying.

$25–550/mo · coverage-dependent
How to check →
NexLife · 12-month plan · verified 2026-08-20
$139/mo

Dose-flat and rate-locked ("Flat Forever") with $0 membership, $0 consults, supplies included, cancel on 30 days' notice. No countdown timer on this banner — a rate lock in writing beats fake urgency every time. Operator relationship disclosed.

See the verified plan →
What's locked instead of ticking
$139rate lock
$0fees
30dexit
dated
Popular comparisons
Free tools · no signup

Play with your numbers

Or read the raw ledger →

GLP-1 Market Timeline — what's verified, what's watch

Dated events trace to the sources shelf; purple items are expectations, not facts.

  • Dec 2024Zepbound approved for obstructive sleep apnea

    First drug approval for OSA in adults with obesity (SURMOUNT-OSA).

  • Dec 2024FDA: tirzepatide shortage resolved

    Off the shortage list after the October determination and re-review.

  • Feb 2025Semaglutide shortage resolved

    Feb 21 determination starts the clock on compounding copies.

  • Feb–May 2025Compounding cutoffs pass

    503A then 503B deadlines for tirzepatide (Feb 18 / Mar 19) and semaglutide (Apr 22 / May 22); straight copies end.

  • 2025Lilly & Novo sue compounders and telehealth sellers

    The "personalized dosing" lane becomes contested litigation territory.

  • Jul 2025Largest PBM prefers Wegovy

    CVS Caremark's formulary decision reshapes which drug is "affordable" for millions.

  • 2025Orforglipron phase-3 readouts (ATTAIN)

    Small-molecule daily pill posts ~12% weight loss; filing expected to follow.

  • Late 2025Oral semaglutide 25 mg under FDA review

    Higher-dose pill for weight management submitted; verify current status.

  • 2026 watchOral-pill decisions & further enforcement

    Expected, not occurred: oral approvals, continued compounding enforcement, more price moves in manufacturer-direct programs.

Latest from the Journal

All articles →

Explore resources

All tracked providers: NexLife · Ro · Hims · Hers · Henry Meds · Orderly Meds · Found · Mochi Health · Remedy Meds · Shed · Fifty 410 — 1 verified, 10 pending under the public queue; full field on the rankings page.

Not sure which program is right for you?

Answer 6 quick questions and get a shortlist matched to your budget, insurance, and goals — including "check your coverage first" when that's the honest answer.

Take the 2-Minute Quiz →